Extraction of somatostatin from human plasma on octadecylsilyl silica

B. Vasquez, V. Harris, Roger H Unger

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Human plasma contains substances that interfere with the radioimmunoassay (RIA) of somatostatin-like immunoreactivity (SLI). A method has been developed for rapid, reproducible extraction of somatostatin from human plasma on octadecyldilylsilica (ODS). Hydrophobic binding of somatostatin to ODS permitted extraction of this peptide from untreated human plasma, elution of less tightly bound substances with dilute acid, and then elution of somatostatin by 80:20 acetonitrile:0.1% trifluoroacetic acid. The lyophilized extract was reconstituted to a volume of 0.5 ml prior to quantification by RIA. This 6-fold concentration resulted in an effective lower limit of detection of 7.5 pg/ml of plasma. The interassay coefficient of variation for the combined extraction and RIA was 20% (n=10) at a mean plasma level of 15 pg/ml. Basal concentrations of somatostatin in human plasma ranged from 8 to 20 pg/ml (n=35, x̄=13.3±0.4). Basal somatostatin levels (x̄=14.0±0.4 pg/ml) for nonobese (BMI<30, n=10) were not different from values (x̄=13.3±0.7 pg/ml) observed for the obese group (BMI>35, n=17) nor from the values (n=8, x=15.4±1.2 pg/ml) obtained for subjects with non-insulin dependent diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)807-809
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume55
Issue number4
StatePublished - 1982

Fingerprint

Plasma (human)
Somatostatin
Radioimmunoassay
Plasmas
Trifluoroacetic Acid
Medical problems
Type 2 Diabetes Mellitus
Limit of Detection
octadecylsilica
Peptides
Acids

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Extraction of somatostatin from human plasma on octadecylsilyl silica. / Vasquez, B.; Harris, V.; Unger, Roger H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 55, No. 4, 1982, p. 807-809.

Research output: Contribution to journalArticle

@article{cbe6d38afd7d489a84117e3bcd3c79d4,
title = "Extraction of somatostatin from human plasma on octadecylsilyl silica",
abstract = "Human plasma contains substances that interfere with the radioimmunoassay (RIA) of somatostatin-like immunoreactivity (SLI). A method has been developed for rapid, reproducible extraction of somatostatin from human plasma on octadecyldilylsilica (ODS). Hydrophobic binding of somatostatin to ODS permitted extraction of this peptide from untreated human plasma, elution of less tightly bound substances with dilute acid, and then elution of somatostatin by 80:20 acetonitrile:0.1{\%} trifluoroacetic acid. The lyophilized extract was reconstituted to a volume of 0.5 ml prior to quantification by RIA. This 6-fold concentration resulted in an effective lower limit of detection of 7.5 pg/ml of plasma. The interassay coefficient of variation for the combined extraction and RIA was 20{\%} (n=10) at a mean plasma level of 15 pg/ml. Basal concentrations of somatostatin in human plasma ranged from 8 to 20 pg/ml (n=35, x̄=13.3±0.4). Basal somatostatin levels (x̄=14.0±0.4 pg/ml) for nonobese (BMI<30, n=10) were not different from values (x̄=13.3±0.7 pg/ml) observed for the obese group (BMI>35, n=17) nor from the values (n=8, x=15.4±1.2 pg/ml) obtained for subjects with non-insulin dependent diabetes mellitus.",
author = "B. Vasquez and V. Harris and Unger, {Roger H}",
year = "1982",
language = "English (US)",
volume = "55",
pages = "807--809",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Extraction of somatostatin from human plasma on octadecylsilyl silica

AU - Vasquez, B.

AU - Harris, V.

AU - Unger, Roger H

PY - 1982

Y1 - 1982

N2 - Human plasma contains substances that interfere with the radioimmunoassay (RIA) of somatostatin-like immunoreactivity (SLI). A method has been developed for rapid, reproducible extraction of somatostatin from human plasma on octadecyldilylsilica (ODS). Hydrophobic binding of somatostatin to ODS permitted extraction of this peptide from untreated human plasma, elution of less tightly bound substances with dilute acid, and then elution of somatostatin by 80:20 acetonitrile:0.1% trifluoroacetic acid. The lyophilized extract was reconstituted to a volume of 0.5 ml prior to quantification by RIA. This 6-fold concentration resulted in an effective lower limit of detection of 7.5 pg/ml of plasma. The interassay coefficient of variation for the combined extraction and RIA was 20% (n=10) at a mean plasma level of 15 pg/ml. Basal concentrations of somatostatin in human plasma ranged from 8 to 20 pg/ml (n=35, x̄=13.3±0.4). Basal somatostatin levels (x̄=14.0±0.4 pg/ml) for nonobese (BMI<30, n=10) were not different from values (x̄=13.3±0.7 pg/ml) observed for the obese group (BMI>35, n=17) nor from the values (n=8, x=15.4±1.2 pg/ml) obtained for subjects with non-insulin dependent diabetes mellitus.

AB - Human plasma contains substances that interfere with the radioimmunoassay (RIA) of somatostatin-like immunoreactivity (SLI). A method has been developed for rapid, reproducible extraction of somatostatin from human plasma on octadecyldilylsilica (ODS). Hydrophobic binding of somatostatin to ODS permitted extraction of this peptide from untreated human plasma, elution of less tightly bound substances with dilute acid, and then elution of somatostatin by 80:20 acetonitrile:0.1% trifluoroacetic acid. The lyophilized extract was reconstituted to a volume of 0.5 ml prior to quantification by RIA. This 6-fold concentration resulted in an effective lower limit of detection of 7.5 pg/ml of plasma. The interassay coefficient of variation for the combined extraction and RIA was 20% (n=10) at a mean plasma level of 15 pg/ml. Basal concentrations of somatostatin in human plasma ranged from 8 to 20 pg/ml (n=35, x̄=13.3±0.4). Basal somatostatin levels (x̄=14.0±0.4 pg/ml) for nonobese (BMI<30, n=10) were not different from values (x̄=13.3±0.7 pg/ml) observed for the obese group (BMI>35, n=17) nor from the values (n=8, x=15.4±1.2 pg/ml) obtained for subjects with non-insulin dependent diabetes mellitus.

UR - http://www.scopus.com/inward/record.url?scp=0020461152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020461152&partnerID=8YFLogxK

M3 - Article

C2 - 6125526

AN - SCOPUS:0020461152

VL - 55

SP - 807

EP - 809

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -